Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Min Li, Cheng-Zhi Zhou, Jin-Ji Yang, Shun Lu, Di Zheng, Jie Hu, Hui Zeng, You Lu, Kai-Hua Lu, Shu-Ang Li, Xin-Ru Mao, Han Han-Zhang, Analyn Lizaso, Jun-Yi Ye & Cheng-Ping Hu. (2019) The in cis compound EGFR mutations in Chinese advanced non-small cell lung cancer patients. Cancer Biology & Therapy 20:8, pages 1097-1104.
Read now
Read now
Min Li, Bing-Rong Zhao, Shi-Qing Liu, Jian An, Peng-Bo Deng, Han Han-Zhang, Jun-Yi Ye, Xin-Ru Mao, Shao-Kun Chuai & Cheng-Ping Hu. (2018) Mutational landscape and clonal diversity of pulmonary adenoid cystic carcinoma. Cancer Biology & Therapy 19:10, pages 898-903.
Read now
Read now
Liming Cao, Long Long, Min Li, Huaping Yang, Pengbo Deng, Xinru Mao, Jianxing Xiang, Bing Li, Tengfei Zhang & Chengping Hu. (2018) The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients. OncoTargets and Therapy 11, pages 2637-2646.
Read now
Read now
Articles from other publishers (37)
Nastaran Karimi & Seyed Javad Moghaddam. (2023) KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions. Cells 12:5, pages 749.
Crossref
Crossref
Jun-Ling Wang, Yu-Dong Fu, Yan-Hong Gao, Xiu-Ping Li, Qian Xiong, Rui Li, Bo Hou, Ruo-Shan Huang, Jun-Feng Wang, Jian-Kun Zhang, Jia-Ling Lv, Chao Zhang & Hong-Wei Li. (2022) Unique characteristics of G719X and S768I compound double mutations of epidermal growth factor receptor (EGFR) gene in lung cancer of coal-producing areas of East Yunnan in Southwestern China. Genes and Environment 44:1.
Crossref
Crossref
Hui Deng, Qian Lei, Chengdi Wang, Zhoufeng Wang, Hai Chen, Gang Wang, Na Yang, Dan Huang, Quanwei Yu, Mengling Yao, Xue Xiao, Guonian Zhu, Cheng Cheng, Yangqian Li, Feng Li, Panwen Tian & Weimin Li. (2022) A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations. Nature Communications 13:1.
Crossref
Crossref
Jing Zhu, Yalun Li, Xiaoai Wu, Yunchun Li, Li Wang & Hong Fan. (2022)
In vivo
PET Imaging of EGFR Expression: An Overview of Radiolabeled
EGFR TKIs
. Current Topics in Medicinal Chemistry 22:28, pages 2329-2342.
Crossref
Crossref
Jinzhao Zhai, Jiangyue Lu, Zhibo Zhang, Yuan Wang, Xiaoyan Li, Sujie Zhang, Shuai Mu, Xiaoyu Zhi, Xiangwei Ge, Di Lu, Yi Hu & Jinliang Wang. (2022)
First‐line
PD
‐1/
PD‐L1
inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non‐squamous non‐small cell lung cancer: A Bayesian network meta‐analysis of randomized controlled trials
. Cancer Medicine 11:10, pages 2043-2055.
Crossref
Crossref
Mo Shen, Rongbin Qi, Justin Ren, Dongqing Lv & Haihua Yang. (2022) Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Li Liu, Farhin Shaheed Kalyani, Haiyan Yang, Chunhua Zhou, Yi Xiong, Songlin Zhu, Nong Yang & Jingjing Qu. (2021) Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study. Frontiers in Oncology 11.
Crossref
Crossref
Keith M. Kerr, Frédéric Bibeau, Erik Thunnissen, Johan Botling, Aleš Ryška, Jürgen Wolf, Katarina Öhrling, Peter Burdon, Umberto Malapelle & Reinhard Büttner. (2021) The evolving landscape of biomarker testing for non-small cell lung cancer in Europe. Lung Cancer 154, pages 161-175.
Crossref
Crossref
Senlin Ye, Haohui Wang, Kancheng He, Hongwei Shen, Mou Peng, Yeqi Nian, Rongrong Cui & Lu Yi. (2020) Gene set based systematic analysis of prostate cancer and its subtypes. Future Oncology 16:2, pages 4381-4393.
Crossref
Crossref
Alexandra Grosse, Claudia Grosse, Markus Rechsteiner & Alex Soltermann. (2019) Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland. Diagnostic Pathology 14:1.
Crossref
Crossref
Claudia Grosse, Alex Soltermann, Markus Rechsteiner & Alexandra Grosse. (2019) Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome. PLOS ONE 14:8, pages e0220691.
Crossref
Crossref
Dhoha Dhieb, Imen Belguith, Laura Capelli, Elisa Chiadini, Matteo Canale, Sara Bravaccini, Ilhem Yangui, Ons Boudawara, Rachid Jlidi, Tahya Boudawara, Daniele Calistri, Leila Ammar Keskes & Paola Ulivi. (2019) Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma. Cells 8:6, pages 514.
Crossref
Crossref
Hao Bai, Jinjing Xia, Xiaokai Zhao, Ziying Gong, Daoyun Zhang & liwen Xiong. (2019)
Detection of
EGFR
mutations using target capture sequencing in plasma of patients with non-small-cell lung cancer
. Journal of Clinical Pathology 72:5, pages 379-385.
Crossref
Crossref
Ying Chen, Guangjian Li, Yujie Lei, Kaiyun Yang, Huatao Niu, Jie Zhao, Rui He, Huanqi Ning, Qiubo Huang, Qinghua Zhou & Yunchao Huang. (2019) Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non‐small cell lung cancer. Thoracic Cancer 10:4, pages 695-707.
Crossref
Crossref
Chun-wei Xu, Wen-xian Wang, Yan-ping Chen, Yu Chen, Wei Liu, Li-hua Zhong, Fang-fang Chen, Wu Zhuang, Zheng-bo Song, Xiao-hui Chen, Yun-jian Huang, Yan-fang Guan, Xin Yi, Tang-feng Lv, Wei-feng Zhu, Jian-ping Lu, Xiao-jiang Wang, Yi Shi, Xian-dong Lin, Gang Chen & Yong Song. (2018) Simultaneous VENTANA IHC and RT-PCR testing of ALK status in Chinese non-small cell lung cancer patients and response to crizotinib. Journal of Translational Medicine 16:1.
Crossref
Crossref
Dmitry V. Kazakov, Liubov Kyrpychova, Petr Martinek, Petr Grossmann, Petr Steiner, Tomas Vanecek, Michal Pavlovsky, Vladimir Bencik, Michael Michal & Michal Michal. (2018) ALK Gene Fusions in Epithelioid Fibrous Histiocytoma: A Study of 14 Cases, With New Histopathological Findings. The American Journal of Dermatopathology 40:11, pages 805-814.
Crossref
Crossref
Jing Zhao, Xiaotong Chen, Jing Zheng, Mei Kong, Bo Wang & Wei Ding. (2018)
A genomic and clinicopathological study of non-small-cell lung cancers with discordant
ROS1
gene status by fluorescence
in-situ
hybridisation and immunohistochemical analysis
. Histopathology 73:1, pages 19-28.
Crossref
Crossref
Hind Berradi, Houda Kaanane, Nadia El Kadmiri & Sellama Nadifi. (2018) Concomitance of EGFR mutations and ALK rearrangement in patients with Lung Cancer. Gene Reports 11, pages 196-204.
Crossref
Crossref
Xilin Sun, Zunyu XiaoGongyan ChenZhaoguo HanYang LiuChongqing ZhangYingying SunYan SongKai WangFang FangXiance WangYanhong LinLili XuLiming ShaoJin Li, Zhen Cheng, Sanjiv Sam Gambhir & Baozhong Shen. (2018) A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management. Science Translational Medicine 10:431.
Crossref
Crossref
Lianghua Fang, Hui Chen, Zhenya Tang, Neda Kalhor, Ching-Hua Liu, Hui Yao, Shimin Hu, Pei Lin, Jin Zhao, Raja Luthra, Rajesh R. Singh, Mark J. Routbort, David Hong, L. Jeffrey Medeiros & Xinyan Lu. (2018)
MET
amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer
. Oncotarget 9:16, pages 12959-12970.
Crossref
Crossref
Qiqi Gao, Honghai Ma, Bo Wang, Yake Yao, Jianya Zhou & Jianying Zhou. (2017) Comparison of ALK status between primary and corresponding lymph node metastatic tumors in lung cancer patients. Oncotarget 8:65, pages 108840-108847.
Crossref
Crossref
Chongze Yuan, Hong Hu, Muyu Kuang, Zongwei Chen, Xiaoting Tao, Shengjian Fang, Yihua Sun, Yawei Zhang & Haiquan Chen. (2017)
Super enhancer associated
RAI14
is a new potential biomarker in lung adenocarcinoma
. Oncotarget 8:62, pages 105251-105261.
Crossref
Crossref
Yijun Jia, Tao Jiang, Xuefei Li, Chao Zhao, Limin Zhang, Sha Zhao, Xiaozhen Liu, Meng Qiao, Jiawei Luo, Jinpeng Shi, Hui Yang, Yan Wang, Lei Xi, Shijia Zhang, Guanghui Gao, Chunxia Su, Shengxiang Ren & Caicun Zhou. (2017) Characterization of distinct types of KRAS mutation and its impact on first‑line platinum‑based chemotherapy in Chinese patients with advanced non‑small cell lung cancer. Oncology Letters.
Crossref
Crossref
Bing Wei, Pengfei Ren, Chengjuan Zhang, Zhizhong Wang, Bing Dong, Ke Yang, Jiuzhou Zhao, Shichun Tu, Jie Ma & Yongjun Guo. (2017) Characterization of common and rare mutations in EGFR and associated clinicopathological features in a large population of Chinese patients with lung cancer. Pathology - Research and Practice 213:7, pages 749-758.
Crossref
Crossref
Dimitra Repana & James Spicer. 2017. Pathology and Epidemiology of Cancer. Pathology and Epidemiology of Cancer
347
366
.
Luka Brcic, Marko Jakopovic, Marija Misic, Fran Seiwerth, Izidor Kern, Silvana Smojver-Jezek, Franz Quehenberger, Miroslav Samarzija & Sven Seiwerth. (2016) Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia. Diagnostic Pathology 11:1.
Crossref
Crossref
Aaron M. Chapman, Kathie Y. Sun, Peter Ruestow, Dallas M. Cowan & Amy K. Madl. (2016) Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers. Lung Cancer 102, pages 122-134.
Crossref
Crossref
Jung-Soo Pyo, Guhyun Kang, Won Jin Cho & Sang Bong Choi. (2016) Clinicopathological significance and concordance analysis of c-MET immunohistochemistry in non-small cell lung cancers: A meta-analysis. Pathology - Research and Practice 212:8, pages 710-716.
Crossref
Crossref
Yan Wang, Yu Liu, Chao Zhao, Xuefei Li, Chunyan Wu, Likun Hou, Shijia Zhang, Tao Jiang, Xiaoxia Chen, Chunxia Su, Guanghui Gao, Wei Li, Fengying Wu, Aiwu Li, Shengxiang Ren, Caicun Zhou & Jun Zhang. (2016) Feasibility of cytological specimens for ALK fusion detection in patients with advanced NSCLC using the method of RT-PCR. Lung Cancer 94, pages 28-34.
Crossref
Crossref
Eason Leong Yin Chan, Claudia Ho Yi Chin & Vivian Wai Yan Lui. (2016) An update of ALK inhibitors in human clinical trials. Future Oncology 12:1, pages 71-81.
Crossref
Crossref
Yan Wang, Jun Zhang, Guanghui Gao, Xuefei Li, Chao Zhao, Yayi He, Chunxia Su, Shijia Zhang, Xiaoxia Chen, Jie Zhang, Wei Li, Bing Li, Jing Zhao, Likun Hou, Chunyan Wu, Shengxiang Ren, Caicun Zhou & Jun Zhang. (2015) EML4-ALK Fusion Detected by RT-PCR Confers Similar Response to Crizotinib as Detected by FISH in Patients with Advanced Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology 10:11, pages 1546-1552.
Crossref
Crossref
Lan-Ying Gou, Fei-Yu Niu, Yi-Long Wu & Wen-Zhao Zhong. (2015) Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population. Cancer 121:S17, pages 3069-3079.
Crossref
Crossref
Dominic Leiser, Michaela Medová, Kei Mikami, Lluís Nisa, Deborah Stroka, Andree Blaukat, Friedhelm Bladt, Daniel M. Aebersold & Yitzhak Zimmer. (2015) KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells. Molecular Oncology 9:7, pages 1434-1446.
Crossref
Crossref
Anna C. Navis, Sanne A. M. van Lith, Sander M. J. van Duijnhoven, Maaike de Pooter, Bahar Yetkin-Arik, Pieter Wesseling, Wiljan J. A. J. Hendriks, Hanka Venselaar, Marco Timmer, Patricia van Cleef, Paul van Bergen en Henegouwen, Myron G. Best, Thomas D. Wurdinger, Bastiaan B. J. Tops & William P. J. Leenders. (2015) Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular protein. Acta Neuropathologica 130:1, pages 131-144.
Crossref
Crossref
Denis L.F. Jardim, Chad Tang, Debora De Melo Gagliato, Gerald S. Falchook, Kenneth Hess, Filip Janku, Siqing Fu, Jennifer J. Wheler, Ralph G. Zinner, Aung Naing, Apostolia M. Tsimberidou, Vijaykumar Holla, Marylin M. Li, Sinchita Roy-Chowdhuri, Raja Luthra, Ravi Salgia, Razelle Kurzrock, Funda Meric-Bernstam & David S. Hong. (2014)
Analysis of 1,115 Patients Tested for
MET
Amplification and Therapy Response in the MD Anderson Phase I Clinic
. Clinical Cancer Research 20:24, pages 6336-6345.
Crossref
Crossref
Jiandong Wang, Qin Shen, Qunli Shi, Bo Yu, Xuan Wang, Kai Cheng, Guangming Lu & Xiaojun Zhou. (2014) Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry. Journal of Experimental & Clinical Cancer Research 33:1.
Crossref
Crossref
Guiyuan Li, Shengming Yi, Fan Yang, Yongxin Zhou, Qiang Ji, Jianzhi Cai & Yunqing Mei. (2014) Identification of mutant genes with high-frequency, high-risk, and high-expression in lung adenocarcinoma. Thoracic Cancer 5:3, pages 211-218.
Crossref
Crossref